InvestorsHub Logo
Followers 1
Posts 125
Boards Moderated 0
Alias Born 04/11/2013

Re: None

Wednesday, 12/17/2014 12:33:03 PM

Wednesday, December 17, 2014 12:33:03 PM

Post# of 40492
A solid add to the Team today.The newest member of INO helped commercialize zytiga. Zytiga is estimated at $2.3B a year in sales by 2018. This opens pathways for more Prostate cancer deals for INO.


http://ir.inovio.com/news/news-releases/news-releases-details/2014/Inovio-Pharmaceuticals-Appoints-Zane-Yang-MD-Vice-President-Clinical-Development-Oncology/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News